Aclarion (ACON) Competitors $8.98 -0.12 (-1.32%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$8.94 -0.04 (-0.50%) As of 04/17/2025 04:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ACON vs. CCM, ENZ, MRAI, BRTX, KDLY, MGRX, OTRK, SSY, ATPC, and ATIPShould you be buying Aclarion stock or one of its competitors? The main competitors of Aclarion include Concord Medical Services (CCM), Enzo Biochem (ENZ), Marpai (MRAI), BioRestorative Therapies (BRTX), Kindly MD (KDLY), Mangoceuticals (MGRX), Ontrak (OTRK), SunLink Health Systems (SSY), Agape ATP (ATPC), and ATI Physical Therapy (ATIP). These companies are all part of the "healthcare" industry. Aclarion vs. Concord Medical Services Enzo Biochem Marpai BioRestorative Therapies Kindly MD Mangoceuticals Ontrak SunLink Health Systems Agape ATP ATI Physical Therapy Aclarion (NASDAQ:ACON) and Concord Medical Services (NYSE:CCM) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, community ranking, analyst recommendations, media sentiment, dividends, valuation, risk, profitability and institutional ownership. Do institutionals & insiders believe in ACON or CCM? 7.5% of Aclarion shares are held by institutional investors. 0.8% of Aclarion shares are held by company insiders. Comparatively, 46.5% of Concord Medical Services shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Does the MarketBeat Community favor ACON or CCM? Concord Medical Services received 193 more outperform votes than Aclarion when rated by MarketBeat users. However, 80.00% of users gave Aclarion an outperform vote while only 58.98% of users gave Concord Medical Services an outperform vote. CompanyUnderperformOutperformAclarionOutperform Votes480.00% Underperform Votes120.00% Concord Medical ServicesOutperform Votes19758.98% Underperform Votes13741.02% Which has more risk & volatility, ACON or CCM? Aclarion has a beta of 1.08, suggesting that its share price is 8% more volatile than the S&P 500. Comparatively, Concord Medical Services has a beta of -0.64, suggesting that its share price is 164% less volatile than the S&P 500. Is ACON or CCM more profitable? Concord Medical Services has a net margin of 0.00% compared to Aclarion's net margin of -12,845.05%. Concord Medical Services' return on equity of 0.00% beat Aclarion's return on equity.Company Net Margins Return on Equity Return on Assets Aclarion-12,845.05% -422.87% -201.15% Concord Medical Services N/A N/A N/A Does the media prefer ACON or CCM? In the previous week, Aclarion and Aclarion both had 1 articles in the media. Aclarion's average media sentiment score of 1.00 beat Concord Medical Services' score of 0.00 indicating that Aclarion is being referred to more favorably in the media. Company Overall Sentiment Aclarion Positive Concord Medical Services Neutral Do analysts rate ACON or CCM? Aclarion currently has a consensus price target of $11,758.50, suggesting a potential upside of 130,840.98%. Given Aclarion's stronger consensus rating and higher possible upside, equities analysts plainly believe Aclarion is more favorable than Concord Medical Services.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aclarion 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Concord Medical Services 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has preferable earnings & valuation, ACON or CCM? Aclarion has higher earnings, but lower revenue than Concord Medical Services. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAclarion$49.29K106.04-$4.91MN/AN/AConcord Medical Services$471.70M0.04-$41.93MN/AN/A SummaryAclarion beats Concord Medical Services on 9 of the 15 factors compared between the two stocks. Get Aclarion News Delivered to You Automatically Sign up to receive the latest news and ratings for ACON and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ACON vs. The Competition Export to ExcelMetricAclarionMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$5.23M$2.79B$5.31B$7.35BDividend YieldN/A31.35%5.45%4.31%P/E RatioN/A14.4621.9417.82Price / Sales106.04192.59380.9497.68Price / CashN/A57.5638.2634.64Price / Book-0.074.486.453.98Net Income-$4.91M-$22.21M$3.22B$247.81M7 Day Performance7.80%1.82%5.85%3.19%1 Month Performance-58.43%-8.07%-9.55%-7.70%1 Year Performance-99.67%7.25%11.83%1.49% Aclarion Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ACONAclarion2.3276 of 5 stars$8.98-1.3%$11,758.50+130,841.0%-99.7%$5.23M$49,289.000.007CCMConcord Medical Services0.3947 of 5 stars$4.22+5.0%N/A-23.7%$18.32M$471.70M0.00970Analyst ForecastNews CoverageGap DownHigh Trading VolumeENZEnzo Biochem0.5586 of 5 stars$0.35+6.5%N/A-70.1%$18.08M$29.09M0.00520Analyst ForecastGap DownMRAIMarpaiN/A$1.00+19.0%N/A-54.9%$14.90M$34.87M-0.38150Gap UpBRTXBioRestorative Therapies3.6065 of 5 stars$1.78-0.6%$18.00+911.2%+27.7%$13.36M$401,000.00-1.167Short Interest ↓KDLYKindly MD0.1591 of 5 stars$1.66-3.5%N/AN/A$10.01M$2.72M-2.52N/ANews CoveragePositive NewsMGRXMangoceuticals0.3022 of 5 stars$1.82+16.3%N/A-96.1%$9.41M$615,873.00-0.313Short Interest ↑Negative NewsOTRKOntrak2.813 of 5 stars$1.66+5.8%$45.00+2,610.8%-62.8%$7.00M$11.24M-0.16250Earnings ReportShort Interest ↓Gap UpSSYSunLink Health SystemsN/A$0.85-4.7%N/A+36.0%$5.97M$31.23M6.061,376Analyst ForecastGap UpATPCAgape ATP0.7157 of 5 stars$1.42+7.6%N/A-62.4%$5.67M$1.32M-1.9540Gap UpATIPATI Physical TherapyN/A$1.00-1.0%N/A-77.6%$4.41M$741.86M-0.055,600Gap Down Related Companies and Tools Related Companies Concord Medical Services Competitors Enzo Biochem Competitors Marpai Competitors BioRestorative Therapies Competitors Kindly MD Competitors Mangoceuticals Competitors Ontrak Competitors SunLink Health Systems Competitors Agape ATP Competitors ATI Physical Therapy Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ACON) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredThe real reason gold is soaring (and likely to continue)Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aclarion, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aclarion With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ACON Stock Free ACON Stock Alerts